Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Fosun Pharma to Raise $913 Million in Hong Kong Listing

publication date: Feb 28, 2011
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Fosun Pharmaceutical announced plans for a secondary listing on the Hong Kong exchange. The company hopes to raise as much as 6 billion RMB ($913 million) in an offering that would increase its outstanding shares by up to 20%. Fosun is no stranger to the Hong Kong Exchange: both its parent and a subsidiary have listed there. More details....

Stock Symbol: (SHA: 600196)    Share this with colleagues:  



Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Sponsors